文献速递甲状腺疾病

韩国甲状腺癌筛查增加乳头状癌检出,对其他亚型或甲状腺癌死亡率无影响

Thyroid Cancer Screening in South Korea Increases Detection of Papillary Cancers with No Impact on Other Subtypes or Thyroid Cancer Mortality.
PubMed 文献 · Thyroid · 2016-10-18

该生态学研究利用2010年韩国社区健康调查中226,873名个体的甲状腺癌筛查史,结合2008至2010年癌症登记发病数据和2007至2010年死亡数据,在韩国16个行政区分析筛查与甲状腺癌发病及死亡的关系。结果显示地区筛查率与甲状腺癌发病率强正相关(r=0.77,95%CI 0.70-0.82),仅与乳头状癌检出增加相关(r=0.74,95%CI 0.59-0.88),与甲状腺癌死亡率无关(r=-0.08,95%CI -0.59-0.63)。

要点

  • 地区甲状腺癌筛查率与发病率强正相关(r=0.77,95%CI 0.70-0.82)。
  • 筛查仅与乳头状癌检出增加相关(r=0.74,95%CI 0.59-0.88)。
  • 筛查与甲状腺癌死亡率无关(r=-0.08,95%CI -0.59-0.63)。

核心结论

  • 韩国甲状腺癌筛查与甲状腺癌发病率的相关程度强烈提示筛查是甲状腺癌流行最重要的驱动因素,尤其在女性中。
  • 甲状腺癌筛查仅与乳头状癌这一种组织学类型的增加相关,与甲状腺癌死亡率无任何关联。
  • 机会性甲状腺癌筛查在多大程度上将数千名无症状者转变为癌症患者且无已知获益,需仔细审视。

研究设计与样本

  • 生态学研究,使用2010年韩国社区健康调查询问226,873名个体过去两年是否接受甲状腺癌筛查。
  • 甲状腺癌发病数据取自2008至2010年韩国癌症登记数据,死亡数据取自2007至2010年韩国统计数据库。
  • 按年龄和性别在韩国16个行政区采用一般线性回归模型分析筛查与发病及死亡的生态学关联。

主要发现

  • 2008至2010年间甲状腺癌发病率为每10万人64.1例,女性为107.3,男性为21.1。
  • 地区甲状腺癌筛查与地区甲状腺癌发病率呈强正相关(r=0.77,95%CI 0.70-0.82)。
  • 女性相关性(r=0.88,95%CI 0.83-0.92)高于男性(r=0.76,95%CI 0.67-0.84),见于任何年龄组。
  • 甲状腺筛查仅与乳头状甲状腺癌检出增加相关(r=0.74,95%CI 0.59-0.88)。
  • 甲状腺筛查与甲状腺癌死亡率无关(r=-0.08,95%CI -0.59-0.63)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The incidence of thyroid cancer has increased worldwide. The country where the incidence has increased most is South Korea. The goal of this study is to understand the magnitude of association between opportunistic thyroid cancer screening and thyroid cancer incidence, thyroid cancer subtype, and disease-specific mortality. METHODS: We used the 2010 Korea Community Health Survey, which queried 226,873 individuals if they had been screened for thyroid cancer in the last two years. Thyroid cancer incidence data from 2008 to 2010 were obtained from the Korea Cancer registry data, and mortality data from 2007-2010 were obtained from the Statistics Korea database. The ecological association between thyroid screening and thyroid cancer incidence and mortality by age and sex were examined across Korea's 16 administrative regions by general linear regression models. RESULTS: Between 2008 and 2010, the incidence of thyroid cancer was 64.1 per 100,000 individuals: the incidence in females was 107.3 and in males was 21.1. There was a strong positive correlation between regional thyroid cancer screening and regional thyroid cancer incidence (r = 0.77, [95% confidence interval 0.70-0.82]). The magnitude of correlation was higher for females (r = 0.88 [CI 0.83-0.92]) than in males (r = 0.76 [CI 0.67-0.84]) in any age group. Thyroid screening was only associated with increased detection of papillary thyroid cancer (r = 0.74 [CI 0.59-0.88]); and not associated with mortality (r = -0.08 [CI -0.59-0.63]) due to thyroid cancer. CONCLUSIONS: The magnitude of association between thyroid cancer screening in South Korea and the incidence of thyroid cancer strongly suggests that screening is the most important driver of the epidemic of thyroid cancer, particularly among females. Thyroid cancer screening, however, was only associated with the increase of one tumor histology, papillary thyroid cancer, and it did not have any association with thyroid cancer mortality. The extent to which opportunistic thyroid cancer screening is converting thousands of asymptomatic persons to cancer patients without any known benefit to them needs to be examined carefully.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Ahn HS, Kim HJ, Kim KH, et al. Thyroid Cancer Screening in South Korea Increases Detection of Papillary Cancers with No Impact on Other Subtypes or Thyroid Cancer Mortality. Thyroid. 2016. PMID: 27627550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。